SensDx uses cookies to track visits to our website only, no personal information is collected. By continuing to use the site you are agreeing to our use of cookies.


Stefan Müllner, PhD joins the the SensDx SA Advisory Board


Stefan Müllner, PhD – the long time CEO of the autoimmune diagnostic specialist Protagen AG, Dortmund, Germany, with strong industrial background from management and board positions in the pharma (Hoechst, Aventis), biotech (Maltagen, Phenion, BiotEx, SusTech) consumer products (Henkel) and venture capital industries (fundamenta Capital) and  has joined the Advisory Board of SensDx SA.

Read more

First place for SensDx in the Future Diagnostic category at Roche Innovation Summit


On 18th June 2018 SensDx Digital Diagnostics presented itself at the prestigious Roche Innovation Summit in Basel. Among 150 individually invited companies from MedTech industry, SensDx got into Top 4 winning the category of Future Diagnostics in this way.

Read more

SensDx at the meeting with the Polish goverment


SensDx, as a beneficiary of the National Center for Research and Development projects, was invited to the ceremony approved The Constitution for Science by the Council of Ministers.

Read more

An article by SensDx Researchers in Top 100 Scientific Reports Nature magazine


An article, written by our SensDx Researchers, published in the prestigious Scientific Reports Nature magazine was chosen one of the top 100 in 2017!

Scientific Reportspublished more than 5000 chemistry papers in 2017, and so a position in the top 100 most highly read articles is an extraordinary achievement and great distinction for us.

Read more

SensDx will be presented at the Start-Up Academy Medtec Europe 2018


On November 29, 2017 SensDx won the international competition EIT Health InnoStars and became the first prize winner of € 30,000. Now he has a chance in the next prestigious competition. The SensDx’ s technology have been selected to showcase the product at the Start-Up Academy, Medtec Europe 2018.

Read more

NEUCA Group – leader of the Polish health market invests in SensDx


Neuca Med, subsidiary of NEUCA Group, leading supplier of health products and services in Poland, acquired 24,9% of SensDx shares

Read more

Alex Klarman joined the SensDx team


Alex Klarman joined the SensDx team and he is going to support the company in its international expansion, in particular in the field of Farming 4.0 (precision farming). Dr. Klarman is famous all over the world for his management activity and is the leading expert in the field of critical chain management as well as appreciated authority in the Theory of Constraints (TOC).

Read more

SensDx won the “EIT Health InnoStars Awards” prize


On November 29, 2017 SensDx won the international “EIT Health InnoStars Awards” prize from the European Union’s Horizon 2020 research and innovation programme and received € 30,000. During the final in Naples, selected in two consecutive stages of this prestigious competition, innovative companies from Italy, Portugal, Greece, Hungary and Poland presented their technology, but SensDx was the best!

Read more

SensDx participated in the MEDICA 2017 Healthcare Brokerage Event


SensDx participated in the MEDICA 2017 Healthcare Brokerage Event. This is an exclusive event for companies – part in the pilot program SME Instruments of the European Innovation Council (EIC), pertaining to the European Commission. SensDx was selected and invited to this global meeting of small and medium companies in the medical sector. 

Read more

SensDx in Scientifics Reports Nature magazine


The prestigious Scientifics Reports Nature magazine published an article, written by our SensDx Researchers. It is an online, open access journal from the publishers of Nature, which publishes scientifically valid primary research from all areas of the natural and clinical sciences.

Read more

SensDx in the third and final stage of EIT Health InnoStars contest


SensDx qualified to the third and final stage of the prestigious Innostars contest! At the end of November 8 innovative companies will present not only their technology, but also their business idea in front of experienced consultants.

Read more

SensDx representatives at Asia Pacific MedTech Forum


Asia Pacific MedTech Forum is one of the biggest and most important events in Asia for the MedTech sector. It took place from 7th to 9th November 2017 in the prestigious The Star Performing Arts Center in Singapure. This year the main them was ‘Transforming Healthcare through Innovation’.

Read more

SensDX Contact

SensDx S.A.

District Court for the Capital City of Warsaw in Warsaw
XIII Commercial Department of the National Court Register

KRS: 0000740748

NIP: 5213679076

REGON: 147422840

Share capital: 100 000 zł (paid in full)


ul. Postępu 14B, 02-676 Warszawa

Offices and laboratories

ul. Kładki 24, 80-822 Gdańsk

ul. Bierutowska 57-59, 51-317 Wrocław
(Wrocławski Park Biznesu 3)

ul. Nałęczowska 14, 20-701 Lublin


ul. Kładki 24, 80-822 Gdańsk